Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug Discovery

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1501258

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1501258

Proteomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 247 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global proteomics market has experienced robust growth, with revenues reaching $35.5 billion in 2024. Projections indicate a promising trajectory, with an estimated CAGR of 22.7%, soaring to $149.0556 billion by 2031. This exponential growth is underpinned by a confluence of factors, including technological advancements, increased R&D expenditure, and strategic collaborations among major players.

Factors Driving Market Growth: The proteomics industry is propelled by relentless innovation and research endeavors, facilitated by technological breakthroughs and amplified investments in R&D. Manufacturers are fervently focused on developing state-of-the-art methods and equipment for disease diagnosis, particularly in critical areas like cancer and infectious diseases. Notable contributions from industry leaders like Agilent Technologies, Inc. underscore the significance of technology-driven strategies in product development and market expansion.

Market Challenges and Opportunities: Despite the promising growth trajectory, the proteomics market encounters notable challenges that warrant attention. High product and service costs pose a significant barrier to entry for many stakeholders, particularly research organizations with limited resources and funding. The intricate nature of proteomic analysis further complicates matters, necessitating a high level of expertise to navigate complex methodologies and technologies effectively.

A critical challenge facing the proteomics market is the scarcity of skilled professionals. The specialized nature of proteomic analysis demands a workforce equipped with advanced technical knowledge and expertise. However, the market struggles to meet this demand, leading to a shortage of qualified personnel capable of performing proteomic research and analysis tasks proficiently.

Despite these challenges, the proteomics market presents unique opportunities for innovation and growth. Addressing the skills gap through investment in training programs and educational initiatives can help bridge the divide between demand and supply for skilled professionals. By equipping individuals with the necessary expertise in proteomic analysis techniques and methodologies, these initiatives can foster a pool of qualified talent to drive industry advancements and innovation forward.

Moreover, the challenges posed by high product and service costs underscore the need for innovation in cost-effective solutions and technologies. Market players can explore novel approaches to reduce manufacturing costs and enhance accessibility to proteomic products and services. This includes leveraging advancements in automation, miniaturization, and scalable production processes to streamline operations and lower overall costs.

Additionally, collaboration and knowledge-sharing initiatives can further bolster market growth and innovation. By fostering partnerships between industry stakeholders, academia, and research institutions, the proteomics market can leverage collective expertise and resources to overcome challenges and drive sustainable growth.

Country-wise Insights: The United States stands out as a formidable player in the proteomics market, commanding an impressive market share of 90.3% within North America. This dominance is underpinned by a robust ecosystem of innovation and collaboration. Strategic partnerships, such as the notable alliance between Symphogen and Thermo Fisher Scientific Inc., serve as catalysts for market expansion in the U.S. These collaborations facilitate the exchange of expertise and resources, driving forward advancements in proteomic research and technology.

Similarly, Germany and Japan are emerging as significant contenders in the global proteomics Analysis. Germany's market presence is bolstered by intensified efforts in research and development. The country's proactive approach to fostering innovation, coupled with substantial government support, propels its proteomics market forward. This proactive stance positions Germany as a lucrative hub for proteomic research and investment.

In Japan, robust government backing and a burgeoning focus on R&D initiatives propel market growth. The country's emphasis on fostering innovation in genomics, bioinformatics, and proteomics fuels advancements in the field. Notably, initiatives like the 13th international conference on Proteomics, Genomics, and Bioinformatics in Tokyo underscore Japan's commitment to driving proteomic research and innovation.

Category-wise Insights: The proteomics market experiences significant propulsion due to escalating demand for reagents & kits, essential elements within proteomic research settings. These components play a pivotal role in various analytical processes, facilitating the identification and analysis of proteins. Moreover, the segment benefits from continual technical advancements, exemplified by innovations like three-dimensional (3D)-gel electrophoresis. Such advancements enhance the efficiency and accuracy of proteomic analysis, thereby driving the segment's robust growth.

Additionally, microarray instruments emerge as a pivotal segment within the proteomics market. These instruments enable high-throughput analysis of gene expression patterns, offering invaluable insights into cellular functions and disease mechanisms. As a result, microarray technology finds widespread applications across various fields, including drug discovery and clinical diagnostics. The versatility and scalability of microarray instruments position them as indispensable tools for researchers and clinicians alike, fueling the segment's growth.

Furthermore, the burgeoning field of drug discovery presents a significant growth opportunity within the proteomics market. Advancements in proteomic technologies facilitate the elucidation of protein structures and functions, thereby enhancing the drug development process. With a growing emphasis on personalized medicine, there is an increasing demand for targeted therapies tailored to individual patients. Proteomics plays a pivotal role in this paradigm shift, enabling the identification of biomarkers and therapeutic targets for personalized medication development. As pharmaceutical companies increasingly leverage proteomic insights in their drug discovery endeavors, the segment experiences substantial growth and innovation.

In summary, the proteomics market thrives on the burgeoning demand for reagents & kits, driven by technical advancements and innovations like 3D-gel electrophoresis. Microarray instruments and drug discovery applications emerge as pivotal segments, propelled by advancements in gene expression analysis and personalized medicine. These trends underscore the dynamic nature of the proteomics market and its pivotal role in advancing biomedical research and healthcare.

Competition Analysis: Major players in the global proteomics market are strategically leveraging initiatives such as mergers, acquisitions, and partnerships to bolster their market presence and drive innovation. Key companies like Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Danaher Corporation are at the forefront of integrating novel technologies within their product portfolios. Collaborative ventures, such as Danaher's strategic partnership with Duke University, underscore the industry's commitment to innovation and advancement.

Key Companies' Profile

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Merck KGaA
  • Caprion Proteomics Inc.
  • Bio-Rad Laboratories
  • Luminex Corporation
  • Waters Corporation
  • Promega Corporation
  • Bruker Corporation

Key Segments Covered in Proteomics Industry Research

Component:

  • Instruments
    • Spectrometry
    • Protein Microarray system
    • Chromatography system
    • Surface Plasmon Resonance
    • Electrophoresis
    • Protein Fractionation Systems
    • X-ray Crystallography
  • Reagents & Kits
    • Protein Microarray Reagents
    • X-Ray Crystallography Reagents
    • Spectroscopy Reagents
    • Chromatography Reagents
    • Electrophoresis Reagents
    • Immunoassay Reagents
    • Protein Fractionation Reagents
  • Core Proteomics Services
    • Protein Identification Services
    • Protein Separation Services

Technology:

  • Microarray Instruments
  • X-Ray Crystallography
  • Spectroscopy
  • Chromatography
  • Protein Fractionation Systems
  • Electrophoresis
  • Surface Plasma Resonance Systems

Application:

  • Drug Discovery
  • Clinical Diagnosis
  • Cancer research

End User:

  • Contract research organization (CROs)
  • Research & Academic institutions
  • Pharma & Biotech Companies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Proteomics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Proteomics Market Outlook, 2018 - 2031

  • 3.1. Global Proteomics Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Instruments
        • 3.1.1.1.1. Spectrometry
        • 3.1.1.1.2. Protein Microarray system
        • 3.1.1.1.3. Chromatography system
        • 3.1.1.1.4. Surface Plasmon Resonance
        • 3.1.1.1.5. Electrophoresis
        • 3.1.1.1.6. Protein Fractionation Systems
        • 3.1.1.1.7. X-ray Crystallography
      • 3.1.1.2. Reagents & Kits
        • 3.1.1.2.1. Protein Microarray Reagents
        • 3.1.1.2.2. X-Ray Crystallography Reagents
        • 3.1.1.2.3. Spectroscopy Reagents
        • 3.1.1.2.4. Chromatography Reagents
        • 3.1.1.2.5. Electrophoresis Reagents
        • 3.1.1.2.6. Immunoassay Reagents
        • 3.1.1.2.7. Protein Fractionation Reagents
      • 3.1.1.3. Core Proteomics Services
        • 3.1.1.3.1. Protein Identification Services
        • 3.1.1.3.2. Protein Separation Services
  • 3.2. Global Proteomics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Microarray Instruments
      • 3.2.1.2. X-Ray Crystallography
      • 3.2.1.3. Spectroscopy
      • 3.2.1.4. Chromatography
      • 3.2.1.5. Protein Fractionation Systems
      • 3.2.1.6. Electrophoresis
      • 3.2.1.7. Surface Plasma Resonance Systems
  • 3.3. Global Proteomics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
        • 3.3.1.1.1. Drug Discovery
        • 3.3.1.1.2. Clinical Diagnosis
        • 3.3.1.1.3. Cancer research
  • 3.4. Global Proteomics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Contract research organization (CROs)
      • 3.4.1.2. Research & Academic institutions
      • 3.4.1.3. Pharma & Biotech Companies
  • 3.5. Global Proteomics Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Proteomics Market Outlook, 2018 - 2031

  • 4.1. North America Proteomics Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Instruments
        • 4.1.1.1.1. Spectrometry
        • 4.1.1.1.2. Protein Microarray system
        • 4.1.1.1.3. Chromatography system
        • 4.1.1.1.4. Surface Plasmon Resonance
        • 4.1.1.1.5. Electrophoresis
        • 4.1.1.1.6. Protein Fractionation Systems
        • 4.1.1.1.7. X-ray Crystallography
      • 4.1.1.2. Reagents & Kits
        • 4.1.1.2.1. Protein Microarray Reagents
        • 4.1.1.2.2. X-Ray Crystallography Reagents
        • 4.1.1.2.3. Spectroscopy Reagents
        • 4.1.1.2.4. Chromatography Reagents
        • 4.1.1.2.5. Electrophoresis Reagents
        • 4.1.1.2.6. Immunoassay Reagents
        • 4.1.1.2.7. Protein Fractionation Reagents
      • 4.1.1.3. Core Proteomics Services
        • 4.1.1.3.1. Protein Identification Services
        • 4.1.1.3.2. Protein Separation Services
  • 4.2. North America Proteomics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Microarray Instruments
      • 4.2.1.2. X-Ray Crystallography
      • 4.2.1.3. Spectroscopy
      • 4.2.1.4. Chromatography
      • 4.2.1.5. Protein Fractionation Systems
      • 4.2.1.6. Electrophoresis
      • 4.2.1.7. Surface Plasma Resonance Systems
  • 4.3. North America Proteomics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
        • 4.3.1.1.1. Drug Discovery
        • 4.3.1.1.2. Clinical Diagnosis
        • 4.3.1.1.3. Cancer research
  • 4.4. North America Proteomics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Contract research organization (CROs)
      • 4.4.1.2. Research & Academic institutions
      • 4.4.1.3. Pharma & Biotech Companies
  • 4.5. North America Proteomics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Proteomics Market Outlook, 2018 - 2031

  • 5.1. Europe Proteomics Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Spectrometry
        • 5.1.1.1.2. Protein Microarray system
        • 5.1.1.1.3. Chromatography system
        • 5.1.1.1.4. Surface Plasmon Resonance
        • 5.1.1.1.5. Electrophoresis
        • 5.1.1.1.6. Protein Fractionation Systems
        • 5.1.1.1.7. X-ray Crystallography
      • 5.1.1.2. Reagents & Kits
        • 5.1.1.2.1. Protein Microarray Reagents
        • 5.1.1.2.2. X-Ray Crystallography Reagents
        • 5.1.1.2.3. Spectroscopy Reagents
        • 5.1.1.2.4. Chromatography Reagents
        • 5.1.1.2.5. Electrophoresis Reagents
        • 5.1.1.2.6. Immunoassay Reagents
        • 5.1.1.2.7. Protein Fractionation Reagents
      • 5.1.1.3. Core Proteomics Services
        • 5.1.1.3.1. Protein Identification Services
        • 5.1.1.3.2. Protein Separation Services
  • 5.2. Europe Proteomics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Microarray Instruments
      • 5.2.1.2. X-Ray Crystallography
      • 5.2.1.3. Spectroscopy
      • 5.2.1.4. Chromatography
      • 5.2.1.5. Protein Fractionation Systems
      • 5.2.1.6. Electrophoresis
      • 5.2.1.7. Surface Plasma Resonance Systems
  • 5.3. Europe Proteomics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
        • 5.3.1.1.1. Drug Discovery
        • 5.3.1.1.2. Clinical Diagnosis
        • 5.3.1.1.3. Cancer research
  • 5.4. Europe Proteomics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Contract research organization (CROs)
      • 5.4.1.2. Research & Academic institutions
      • 5.4.1.3. Pharma & Biotech Companies
  • 5.5. Europe Proteomics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Proteomics Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Proteomics Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Spectrometry
        • 6.1.1.1.2. Protein Microarray system
        • 6.1.1.1.3. Chromatography system
        • 6.1.1.1.4. Surface Plasmon Resonance
        • 6.1.1.1.5. Electrophoresis
        • 6.1.1.1.6. Protein Fractionation Systems
        • 6.1.1.1.7. X-ray Crystallography
      • 6.1.1.2. Reagents & Kits
        • 6.1.1.2.1. Protein Microarray Reagents
        • 6.1.1.2.2. X-Ray Crystallography Reagents
        • 6.1.1.2.3. Spectroscopy Reagents
        • 6.1.1.2.4. Chromatography Reagents
        • 6.1.1.2.5. Electrophoresis Reagents
        • 6.1.1.2.6. Immunoassay Reagents
        • 6.1.1.2.7. Protein Fractionation Reagents
      • 6.1.1.3. Core Proteomics Services
        • 6.1.1.3.1. Protein Identification Services
        • 6.1.1.3.2. Protein Separation Services
  • 6.2. Asia Pacific Proteomics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Microarray Instruments
      • 6.2.1.2. X-Ray Crystallography
      • 6.2.1.3. Spectroscopy
      • 6.2.1.4. Chromatography
      • 6.2.1.5. Protein Fractionation Systems
      • 6.2.1.6. Electrophoresis
      • 6.2.1.7. Surface Plasma Resonance Systems
  • 6.3. Asia Pacific Proteomics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
        • 6.3.1.1.1. Drug Discovery
        • 6.3.1.1.2. Clinical Diagnosis
        • 6.3.1.1.3. Cancer research
  • 6.4. Asia Pacific Proteomics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Contract research organization (CROs)
      • 6.4.1.2. Research & Academic institutions
      • 6.4.1.3. Pharma & Biotech Companies
  • 6.5. Asia Pacific Proteomics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Proteomics Market Outlook, 2018 - 2031

  • 7.1. Latin America Proteomics Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Spectrometry
        • 7.1.1.1.2. Protein Microarray system
        • 7.1.1.1.3. Chromatography system
        • 7.1.1.1.4. Surface Plasmon Resonance
        • 7.1.1.1.5. Electrophoresis
        • 7.1.1.1.6. Protein Fractionation Systems
        • 7.1.1.1.7. X-ray Crystallography
      • 7.1.1.2. Reagents & Kits
        • 7.1.1.2.1. Protein Microarray Reagents
        • 7.1.1.2.2. X-Ray Crystallography Reagents
        • 7.1.1.2.3. Spectroscopy Reagents
        • 7.1.1.2.4. Chromatography Reagents
        • 7.1.1.2.5. Electrophoresis Reagents
        • 7.1.1.2.6. Immunoassay Reagents
        • 7.1.1.2.7. Protein Fractionation Reagents
      • 7.1.1.3. Core Proteomics Services
        • 7.1.1.3.1. Protein Identification Services
        • 7.1.1.3.2. Protein Separation Services
  • 7.2. Latin America Proteomics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Microarray Instruments
      • 7.2.1.2. X-Ray Crystallography
      • 7.2.1.3. Spectroscopy
      • 7.2.1.4. Chromatography
      • 7.2.1.5. Protein Fractionation Systems
      • 7.2.1.6. Electrophoresis
      • 7.2.1.7. Surface Plasma Resonance Systems
  • 7.3. Latin America Proteomics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
        • 7.3.1.1.1. Drug Discovery
        • 7.3.1.1.2. Clinical Diagnosis
        • 7.3.1.1.3. Cancer research
  • 7.4. Latin America Proteomics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Contract research organization (CROs)
      • 7.4.1.2. Research & Academic institutions
      • 7.4.1.3. Pharma & Biotech Companies
  • 7.5. Latin America Proteomics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Proteomics Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Proteomics Market Outlook, by Component, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Spectrometry
        • 8.1.1.1.2. Protein Microarray system
        • 8.1.1.1.3. Chromatography system
        • 8.1.1.1.4. Surface Plasmon Resonance
        • 8.1.1.1.5. Electrophoresis
        • 8.1.1.1.6. Protein Fractionation Systems
        • 8.1.1.1.7. X-ray Crystallography
      • 8.1.1.2. Reagents & Kits
        • 8.1.1.2.1. Protein Microarray Reagents
        • 8.1.1.2.2. X-Ray Crystallography Reagents
        • 8.1.1.2.3. Spectroscopy Reagents
        • 8.1.1.2.4. Chromatography Reagents
        • 8.1.1.2.5. Electrophoresis Reagents
        • 8.1.1.2.6. Immunoassay Reagents
        • 8.1.1.2.7. Protein Fractionation Reagents
      • 8.1.1.3. Core Proteomics Services
        • 8.1.1.3.1. Protein Identification Services
        • 8.1.1.3.2. Protein Separation Services
  • 8.2. Middle East & Africa Proteomics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Microarray Instruments
      • 8.2.1.2. X-Ray Crystallography
      • 8.2.1.3. Spectroscopy
      • 8.2.1.4. Chromatography
      • 8.2.1.5. Protein Fractionation Systems
      • 8.2.1.6. Electrophoresis
      • 8.2.1.7. Surface Plasma Resonance Systems
  • 8.3. Middle East & Africa Proteomics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
        • 8.3.1.1.1. Drug Discovery
        • 8.3.1.1.2. Clinical Diagnosis
        • 8.3.1.1.3. Cancer research
  • 8.4. Middle East & Africa Proteomics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Contract research organization (CROs)
      • 8.4.1.2. Research & Academic institutions
      • 8.4.1.3. Pharma & Biotech Companies
  • 8.5. Middle East & Africa Proteomics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Proteomics Market by Component, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Proteomics Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Proteomics Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Proteomics Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Component vs Technology Heatmap
  • 9.2. Manufacturer vs Technology Heatmap
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Agilent Technologies, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Component Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Thermo Fisher Scientific, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Component Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. GE Healthcare
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Component Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Danaher Corporation
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Component Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. PerkinElmer, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Component Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Merck KGaA
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Component Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Caprion Proteomics Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Component Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Bio-Rad Laboratories
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Component Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Luminex Corporation
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Component Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Waters Corporation
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Component Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Promega Corporation
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Component Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bruker Corporation
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Component Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!